OrthoTrophix Presents Clinical Data at European Congress of Rheumatology

52

OAKLAND, Calif.–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/arthritis?src=hash" target="_blank">#arthritis</a>–OrthoTrophix' osteoarthritis drug candidate TPX-100 improved knee function significantly, which correlated with cartilage thickening or stabilization. http://www.businesswire.com/news/home/20190612005016/en/OrthoTrophix-Presents-Clinical-Data-European-Congress-Rheumatology/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==